View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Scientists analyzed tissue samples from patients who had — and had not — responded to a promising new immunotherapy drug. The study could help identify patients most likely to respond to the new drug, which blocks PD-L1.
Follow the highlights of Dana-Farber physicians and scientists at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, December 6-9, 2014. Learn about our presentations of advances in blood and cancer research — including leukemia, lymphoma, multiple myeloma, and other blood disorders.
Three Dana-Farber Cancer Institute faculty are named Fellows of the American Association for the Advancement of Science (AAAS).
Scientists will be better able to trace how genetic changes give rise to diseases ranging from cancer to Huntington’s disease with a new map of protein-protein interactions within human cells produced by researchers at the Center for Cancer Systems Biology (CCSB) at Dana-Farber and associates around the world.
A research team led by Dana-Farber Cancer Institute and Brigham and Women’s Hospital has uncovered surprising new findings that underscore the role of an important signaling pathway, already known to be critical in cancer, in the development of type 2 diabetes.
Dr. Stephen Sallan commented on drugmakers neglecting to fund research on pediatric cancers.
Researchers at Dana-Farber’s Center for Cancer Systems Biology produced a new human interactome map, based on a systematic screen of 13,000 human proteins that uncovered 14,000 protein-protein interactions.
WBZ-TV profiled the Young Adult Program at Dana-Farber. Program director Karen Fasciano says they help patients aged 18-39 with the unique circumstances they face living with cancer.
Former “NBC Nightly News” anchor Tom Brokaw, who was diagnosed with multiple myeloma in 2013, toured Dana-Farber and spoke at the Visiting Committee dinner.
Dr. Anne Partridge commented on a study that found double mastectomies do not improve the chances of survival for women at average risk of breast cancer recurrence.
Dr. Patrick Wen commented on a study about an electrical device glued to the scalp that can slow glioblastoma growth and prolong survival.
Dr. Edward J. Benz, Jr., talked about research to develop treatments for cancer that are more efficient and less toxic, by specifically targeting tumors using genetic analysis.
Caregiver Support Group(2)
12:00 PM - 1:30 PM
Support for caregivers and family members of cancer patients.Facilitated by Ruth Cope, Ph.D., LICSWRegistration required. Please call Ruth Cope: 617-817-6280
Sarcoma Support Group
12:30 PM - 1:30 PM
Smith Building, Room 330
Sarcoma Support Group
Dana-Farber's Mammography Van(59)
The Dimock Center
Dana-Farber's Mammography Van brings state-of-the-art breast cancer screening to the women of Greater Boston. To learn more or schedule an appointment, please call 617-632-1974.
Patient referral information, clinical resources and more.
For adults:877-442-3324For children:888-733-4662Or complete the online form.
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: